Article citationsMore>>

Gerstein, H.C., Sattar, N., Rosenstock, J., Ramasundarahettige, C., Pratley, R., Lopes, R.D., et al. (2021) Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes. New England Journal of Medicine, 385, 896-907.
https://doi.org/10.1056/nejmoa2108269

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top